These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16876818)

  • 21. Alterations in energy metabolism in cardiomyopathies.
    Taha M; Lopaschuk GD
    Ann Med; 2007; 39(8):594-607. PubMed ID: 17934906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
    Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
    Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
    J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice.
    Montgomery RL; Potthoff MJ; Haberland M; Qi X; Matsuzaki S; Humphries KM; Richardson JA; Bassel-Duby R; Olson EN
    J Clin Invest; 2008 Nov; 118(11):3588-97. PubMed ID: 18830415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression.
    van den Brink OW; Delbridge LM; Pedrazzini T; Rosenfeldt FL; Pepe S
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):153-9. PubMed ID: 18205093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired energetics in heart failure - a new therapeutic target.
    Ormerod JO; Ashrafian H; Frenneaux MP
    Pharmacol Ther; 2008 Sep; 119(3):264-74. PubMed ID: 18602947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism.
    Qi D; Rodrigues B
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E654-67. PubMed ID: 17077342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart.
    Jahanyar J; Youker KA; Loebe M; Assad-Kottner C; Koerner MM; Torre-Amione G; Noon GP
    J Surg Res; 2007 Jun; 140(2):199-203. PubMed ID: 17418861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Planta Med; 2009 Feb; 75(2):113-20. PubMed ID: 19096994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.
    Tokarska-Schlattner M; Wallimann T; Schlattner U
    C R Biol; 2006 Sep; 329(9):657-68. PubMed ID: 16945832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
    Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invited commentary.
    Selzman C
    Ann Thorac Surg; 2007 May; 83(5):1758-9. PubMed ID: 17462394
    [No Abstract]   [Full Text] [Related]  

  • 36. Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload.
    Ito K; Hirooka Y; Sunagawa K
    Circ Res; 2009 Apr; 104(8):1004-11. PubMed ID: 19299647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
    Zhang YG; Li YG; Liu BG; Wei RH; Wang DM; Tan XR; Bu DF; Pang YZ; Tang CS
    Acta Pharmacol Sin; 2007 Jan; 28(1):36-43. PubMed ID: 17184580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newly developed angiotensin II-infused experimental models in vascular biology.
    Qin Z
    Regul Pept; 2008 Oct; 150(1-3):1-6. PubMed ID: 18562020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac energy metabolism in obesity.
    Lopaschuk GD; Folmes CD; Stanley WC
    Circ Res; 2007 Aug; 101(4):335-47. PubMed ID: 17702980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.